Kwality Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

867.00

+5.15 (+0.60%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

867.00

+5.15 (+0.60%)
16:01 Dec 20

Quality

86/100
High Financial Strength

Valuation

52/100
Affordable Valuation

Technical

55/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	262.01	456.19	251.03	307.17	340.19
Operating Expenses +	233.17	284.52	190.89	240.85	265.88
Raw Material	165.5	203.11	113.26	154.66	171.72
Increase Decrease in Cost	0.09	-2.51	-3.2	-1.48	-2.77
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	15.9	20.15	29.96	32.56	37.05
Miscellaneous Expenses	52.12	71.37	50.95	56.81	59.88
Operating Profit	28.84	171.67	60.14	66.32	74.31
Other Income	1.59	3.51	2.94	1.83	1.7
Depreciation	6.49	10.69	14.96	19.56	18.53
Interest	2.67	2.92	6.02	10.39	10.98
Profit before tax and exceptio..	21.27	161.57	42.1	38.2	46.5
Exceptional Items	0	0	-16.53	-7.1	-7.1
PBT	21.27	161.57	25.57	31.1	53.6
Provision for Taxation	6.38	41.63	6.29	7.48	10.69
Net Profit	14.89	119.94	19.28	23.62	28.73
NET Profit after MI	15.15	119.99	19.37	23.8	28.88
EPS	14.6	115.64	18.16	22.76	27.66
Operating Profit Margin (%)	11.01	37.63	23.96	21.59	21.84
Net Profit Margin (%)	5.78	26.3	7.72	7.75	8.49

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	54.80	54.80	54.80	54.80	54.80
FII	0.00	0.00	0.00	0.00	0.00
MF	0.00	0.00	0.00	0.00	0.00
Public	45.20	45.20	45.20	45.20	45.20
Others	0.00	0.00	0.00	0.00	0.00
Others	0.00	0.00	0.00	0.00	0.00